Company Name | Entity type | Parent/Subsidiary/Independent | Headquarters | No. of Employees | Annual Revenue ($M) | |
---|---|---|---|---|---|---|
AbbVie Inc | Public | Parent | United States of America | 50,000 | 54,318 | |
Abbvie GK | Private | Subsidiary (of AbbVie Inc ) | Japan | XYZ | XYZ | |
AbbVie Pharmaceutical Trading Shanghai Co Ltd | Private | Subsidiary (of AbbVie Inc ) | China | XYZ | XYZ | |
AbbVie Farmaceutica Ltda | Private | Subsidiary (of AbbVie Inc ) | Brazil | XYZ | XYZ | |
AbbVie SA NV | Private | Subsidiary (of AbbVie Inc ) | Belgium | XYZ | XYZ | |
Neurocrine Biosciences Inc | Public | Parent | United States of America | 1,448 | 1,887 | |
Halozyme Therapeutics Inc | Public | Parent | United States of America | 373 | 829 | |
Allergan Ltd | Private | Subsidiary (of AbbVie Inc) | Ireland | XYZ | XYZ | |
Ironwood Pharmaceuticals Inc | Public | United States of America | 267 | 443 | ||
AbbVie Srl | Private | Subsidiary (of AbbVie Inc ) | Italy | XYZ | XYZ | |
AbbVie GmbH | Private | Subsidiary (of AbbVie Inc ) | Austria | XYZ | XYZ | |
AbbVie SAS | Private | Subsidiary (of AbbVie Inc ) | Colombia | XYZ | XYZ | |
AbbVie Ventures | Private | Subsidiary (of AbbVie Inc ) | United States of America | XYZ | XYZ | |
AbbVie LLC | Private | Subsidiary (of AbbVie Inc ) | Russia | XYZ | XYZ | |
AbbVie Spain SL | Private | Subsidiary (of AbbVie Inc ) | Spain | XYZ | XYZ | |
AbbVie Products LLC | Private | Subsidiary (of AbbVie Inc ) | United States of America | XYZ | XYZ | |
AbbVie A/S | Private | Subsidiary (of AbbVie Inc ) | Denmark | XYZ | XYZ | |
AbbVie Ltd (Thailand) | Private | Subsidiary (of AbbVie Inc ) | Thailand | XYZ | XYZ | |
AbbVie Biopharmaceuticals GmbH | Private | Subsidiary (of AbbVie Inc ) | Switzerland | XYZ | XYZ | |
AbbVie Sdn Bhd | Private | Subsidiary (of AbbVie Inc ) | Malaysia | XYZ | XYZ | |
AbbVie Holdings SAS | Private | Subsidiary (of AbbVie Inc ) | France | XYZ | XYZ | |
AbbVie Biotherapeutics Inc | Private | Subsidiary (of AbbVie Inc ) | United States of America | XYZ | XYZ | |
AbbVie Biopharmaceuticals Ltd | Private | Subsidiary (of AbbVie Inc ) | Israel | XYZ | XYZ | |
AbbVie Holdings KK | Private | Subsidiary (of AbbVie Inc ) | Japan | XYZ | XYZ | |
AbbVie Pty Ltd | Private | Subsidiary (of AbbVie Inc ) | Australia | XYZ | XYZ | |
AbbVie Pte Ltd | Private | Subsidiary (of AbbVie Inc ) | Singapore | XYZ | XYZ | |
AbbVie Ltd (New Zealand) | Private | Subsidiary (of AbbVie Inc ) | New Zealand | XYZ | XYZ | |
AbbVie Biotech Ventures Inc. | Private | Subsidiary (of AbbVie Inc ) | United States of America | XYZ | XYZ | |
AbbVie Farmaceuticos SA de CV | Private | Subsidiary (of AbbVie Inc ) | Mexico | XYZ | XYZ | |
AbbVie Deutschland GmbH & Co KG | Private | Subsidiary (of AbbVie Inc ) | Germany | XYZ | XYZ | |
AbbVie Ltd (Republic of Korea) | Private | Subsidiary (of AbbVie Inc ) | South Korea | XYZ | XYZ | |
Abbott Products GmbH | Private | Independent | Germany | XYZ | XYZ | |
Allergan Productos Farmaceuticos SA | Private | Subsidiary (of AbbVie Inc ) | Argentina | XYZ | XYZ | |
Soliton Inc | Private | Subsidiary (of AbbVie Inc) | United States of America | 13 | XYZ | |
Anima Res GmbH | Private | Independent | Germany | XYZ | XYZ | |
Kos Pharmaceuticals Inc | Private | Subsidiary (of AbbVie Inc ) | United States of America | XYZ | XYZ | |
Argenx SE | Public | Parent | Netherlands | 1,148 | 1,226 | |
Allergan Singapore Pte Ltd | Private | Subsidiary (of AbbVie Inc ) | Singapore | XYZ | XYZ | |
Voyager Therapeutics Inc | Public | Parent | United States of America | 162 | 250 | |
CytomX Therapeutics Inc | Public | Independent | United States of America | 120 | 101 | |
Heptares Therapeutics Ltd | Private | Subsidiary (of Nxera Pharma Co Ltd ) | United Kingdom | XYZ | XYZ | |
Dragonfly Therapeutics Inc | Private | Independent | United States of America | XYZ | XYZ | |
Enanta Pharmaceuticals Inc | Public | Parent | United States of America | 145 | 79 | |
NewBridge Pharmaceuticals FZ LLC | Private | United Arab Emirates | XYZ | XYZ | ||
Capsida Biotherapeutics Inc | Private | Independent | United States of America | XYZ | XYZ | |
Inventiva SA | Public | Parent | France | 112 | 19 | |
Besins Healthcare SA | Private | Monaco | XYZ | XYZ | ||
Voya Global Equity Dividend and Premium Opportunity Fund | Public | Independent | United States of America | XYZ | XYZ | |
Anima Biotech Inc | Private | Parent | United States of America | XYZ | XYZ | |
Editas Medicine Inc | Public | Parent | United States of America | 265 | 78 |
Top Companies
Major players identified by our expert analysts across different sectors, geographies and themes based on metrics like revenues, market cap, funding, and sector KPIs.
You have selected companies to view summary table
Thank You
Your request have been sent, a member of our team will be in touch.
Thank You
Signup notification message here.
Company Comparison
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer